CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: Weekly Dosing of Malarone ® for Prevention of Malaria [Phase 2]
Summary
Phase 2 trial evaluating weekly dosing of Malarone (atovaquone-proguanil) for prevention of malaria. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2013-11-25